Skip to main content
ARWR filings

Corporate insider profile

Daniel Joseph Apel Filing Activity

Latest reported as Chief Financial Officer of ARROWHEAD PHARMACEUTICALS, INC. (ARWR).

Purchase filings
0
Reported companies
1
Net open-market value
-$934,285.04
Latest transaction
Apr 22, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Apr 22, 2026ARROWHEAD PHARMACEUTICALS, INC. (ARWR)Chief Financial OfficerSale13,095$71.35$934,285